Intuitive Surgical: Stock Up Ahead of Quarterly Report

Shares of Intuitive Surgical (NASDAQ:ISRG) closed higher 3.63 percent higher on Monday, one day before the company is to release its fiscal third-quarter earnings report. The jump is attributable in part to JPMorgan upgrading Intuitive Surgical’s stock to Outperform.

The upgrade came in spite of a recent downturn in domestic prostate surgeries, which the firm believes can be more than made up for by increased opportunities in other cancer areas.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

“We find the risk/reward increasingly compelling, in light of the meaningful opportunities emerging in partial nephrectomy, cholecystectomy, colorectal surgery, and other areas – which, collectively, should more than offset the [prostate surgery] softness and drive upside to Street estimates for the next several years,” said JPMorgan analyst Tycho Peterson.

The firm raised earnings per share estimates for the 2012 fiscal year to $14.85 per share, up from $11.57. Intuitive Surgical’s third quarter earnings will be released on Tuesday.

Don’t Miss: Abbott Labs Pops to New All-Time High After Clinical Results.

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Premium Newsletters

Stock Investor Cheat Sheet

Stock Investor Cheat Sheet®

The ultimate Cheat Sheet for finding winning stock picks.
Learn More

Gold & Silver Newsletter

Gold & Silver

Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More

Commodities Premium Newsletter

Commodities Premium

There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more

ETF Investing

ETF Investing

At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business